27
Participants
Start Date
January 27, 2020
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Arm1
Experimental: Total marrow irradiation 1.5 Gray (Gy) twice a daily on days -3 and -2
Arm1
"All patients will receive the following standard conditioning regimen:~Fludarabine 30 mg/m2 IVPB daily from Day -6 (6 days before stem cell infusion) through Day -2"
Arm1
IV cyclophosphamide 14.5 mg/kg intravenously prior to transplant on Days -6 and -5.
Arm 1
Total body irradiation 2Gy on day -1.
Arm1
Stem cell infusion on day 0.
Arm1
Tacrolimus IV initially in doses of 0.15 mg/kg/day for 3 days, followed by conversion to oral therapy (0.15 mg/kg twice daily)
Arm1
Cyclophosphamide on days 3 and 4 after transplant at a dose of 50mg/kg per day
RECRUITING
University of Illinois Cancer Center, Chicago
University of Illinois at Chicago
OTHER